Prospective DUR must be based on the guidelines established by the board and must provide that prior to the prescription being filled or delivered a review will be conducted by the pharmacist at the point of sale to screen for potential drug therapy problems resulting from the following:(1) Therapeutic duplication.(2) Drug-drug interactions.(3) Incorrect dosage and duration of treatment.(4) Drug-allergy interactions.(5) Clinical abuse and misuse.As added by P.L.75-1992, SEC.19.
Indiana Legal Code